MOLN
Price
$3.58
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
135.79M
57 days until earnings call
SNSE
Price
$8.68
Change
+$0.30 (+3.58%)
Updated
Jun 27 closing price
Capitalization
10.94M
32 days until earnings call
Interact to see
Advertisement

MOLN vs SNSE

Header iconMOLN vs SNSE Comparison
Open Charts MOLN vs SNSEBanner chart's image
Molecular Partners AG
Price$3.58
Change-$0.00 (-0.00%)
Volume$6.28K
Capitalization135.79M
Sensei Biotherapeutics
Price$8.68
Change+$0.30 (+3.58%)
Volume$11.51K
Capitalization10.94M
MOLN vs SNSE Comparison Chart in %
Loading...
MOLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MOLN vs. SNSE commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MOLN is a Buy and SNSE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (MOLN: $3.58 vs. SNSE: $8.68)
Brand notoriety: MOLN and SNSE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MOLN: 50% vs. SNSE: 127%
Market capitalization -- MOLN: $135.79M vs. SNSE: $10.94M
MOLN [@Biotechnology] is valued at $135.79M. SNSE’s [@Biotechnology] market capitalization is $10.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MOLN’s FA Score shows that 0 FA rating(s) are green whileSNSE’s FA Score has 1 green FA rating(s).

  • MOLN’s FA Score: 0 green, 5 red.
  • SNSE’s FA Score: 1 green, 4 red.
According to our system of comparison, SNSE is a better buy in the long-term than MOLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MOLN’s TA Score shows that 2 TA indicator(s) are bullish while SNSE’s TA Score has 6 bullish TA indicator(s).

  • MOLN’s TA Score: 2 bullish, 5 bearish.
  • SNSE’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SNSE is a better buy in the short-term than MOLN.

Price Growth

MOLN (@Biotechnology) experienced а -7.97% price change this week, while SNSE (@Biotechnology) price change was +13.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

MOLN is expected to report earnings on Aug 25, 2025.

SNSE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MOLN($136M) has a higher market cap than SNSE($10.9M). SNSE YTD gains are higher at: -11.447 vs. MOLN (-24.600). MOLN has less debt than SNSE: MOLN (2.14M) vs SNSE (3.21M).
MOLNSNSEMOLN / SNSE
Capitalization136M10.9M1,248%
EBITDA-57.15MN/A-
Gain YTD-24.600-11.447215%
P/E RatioN/AN/A-
Revenue2.23MN/A-
Total Cash131MN/A-
Total Debt2.14M3.21M67%
TECHNICAL ANALYSIS
Technical Analysis
MOLNSNSE
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
81%
MACD
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
74%
Declines
ODDS (%)
N/A
Bearish Trend 19 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
MOLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FSNUY12.510.15
+1.21%
Fresenius SE & Co. KGaA
PCELF1.45N/A
N/A
Powercell Sweden AB
PIAC0.07N/A
N/A
Princeton Capital Corporation
QNTQF6.80N/A
N/A
Qinetiq Group Plc.
CYDX0.25N/A
N/A
CYduct Diagnostics Inc.

MOLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MOLN has been loosely correlated with SNSE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MOLN jumps, then SNSE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MOLN
1D Price
Change %
MOLN100%
N/A
SNSE - MOLN
40%
Loosely correlated
+3.58%
ATRA - MOLN
34%
Loosely correlated
N/A
HURA - MOLN
30%
Poorly correlated
-0.45%
BIORQ - MOLN
28%
Poorly correlated
+4.38%
ADXN - MOLN
27%
Poorly correlated
+2.18%
More

SNSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with HURA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then HURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
+3.58%
HURA - SNSE
48%
Loosely correlated
-0.45%
VSTM - SNSE
46%
Loosely correlated
-0.24%
GRI - SNSE
40%
Loosely correlated
-0.78%
MOLN - SNSE
40%
Loosely correlated
N/A
INAB - SNSE
40%
Loosely correlated
-1.39%
More